Načítá se...
First-in-human trial of nanoelectroablation therapy for basal cell carcinoma: Proof of method
This nanoelectroablation therapy effectively treats subdermal murine allograft tumors, autochthonous basal cell carcinoma (BCC) tumors in Ptch1+/−K14-Cre-ER p53 fl/fl mice, and UV-induced melanomas in C57/BL6 HGF/SF mice. Here we describe the first human trial of this modality. We treated 10 BCCs on...
Uloženo v:
| Hlavní autoři: | , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3946678/ https://ncbi.nlm.nih.gov/pubmed/24330263 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/exd.12303 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|